Difference between revisions of "Part:BBa K2624000:Experience"
KKehuandiCPU (Talk | contribs) (→Applications of BBa_K2624000) |
KKehuandiCPU (Talk | contribs) (→Applications of BBa_K2624000) |
||
| Line 9: | Line 9: | ||
https://static.igem.org/mediawiki/2018/archive/5/56/20181017205901%21T--CPU_CHINA--hp-qidongzi.png | https://static.igem.org/mediawiki/2018/archive/5/56/20181017205901%21T--CPU_CHINA--hp-qidongzi.png | ||
| − | + | Figure. The activity of the promoters | |
===User Reviews=== | ===User Reviews=== | ||
Revision as of 03:28, 8 December 2018
This experience page is provided so that any user may enter their experience using this part.
Please enter
how you used this part and how it worked out.
Applications of BBa_K2624000
To improve the selectivity of our system, we utilize hTERT, the cancer-specific promoter, along with HULC, a HCC(Hepatocellular carcinoma)-specific promoter, to open an "AND" gate system to target HCC. We use pGL3-Basic vector, a promoter-less vector for the luciferase assay to determine the transcriptional activity of these promoters. We add the promoters on pGL3-Basic vector and measure the OD value of the luciferase activity. We choose SV40, a highly activated promoter in both cancer cells and normal cells as positive control (PGL3-CON). Results show that hTERT promoter has a good efficiency in cancer cells.
Figure. The activity of the promoters
User Reviews
UNIQ68566808abfe5a97-partinfo-00000000-QINU UNIQ68566808abfe5a97-partinfo-00000001-QINU